SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-013033
Filing Date
2016-11-08
Accepted
2016-11-08 14:23:58
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110816p.htm 10-Q 574710
2 EXHIBIT 10.1 exh_101.htm EX-10.1 59732
3 EXHIBIT 10.2 exh_102.htm EX-10.2 1324
4 EXHIBIT 10.3 exh_103.htm EX-10.3 785848
5 EXHIBIT 31.1 exh_311.htm EX-31.1 11975
6 EXHIBIT 31.2 exh_312.htm EX-31.2 11699
7 EXHIBIT 32.1 exh_321.htm EX-32.1 4667
8 EXHIBIT 32.2 exh_322.htm EX-32.2 4361
15 GRAPHIC exh102_1.jpg GRAPHIC 189657
16 GRAPHIC exh102_2.jpg GRAPHIC 65985
  Complete submission text file 0001171843-16-013033.txt   4976264

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE bcrx-20160930.xml EX-101.INS 583636
10 XBRL SCHEMA FILE bcrx-20160930.xsd EX-101.SCH 48074
11 XBRL CALCULATION FILE bcrx-20160930_cal.xml EX-101.CAL 39469
12 XBRL DEFINITION FILE bcrx-20160930_def.xml EX-101.DEF 357068
13 XBRL LABEL FILE bcrx-20160930_lab.xml EX-101.LAB 330229
14 XBRL PRESENTATION FILE bcrx-20160930_pre.xml EX-101.PRE 359840
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 161980859
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1